Kisqali 400 MG daily dose UU 42S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ3M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,459
Award facts
- Contract value 100% obligated
- $29,458.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,458.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Kisqali 400 mg daily dose tablets in quantities of 42 units. The contract is a non-set-aside award with an ultimate completion date of February 4, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor critical to federal medical procurement and has demonstrated significant capability in fulfilling DLA pharmaceutical requirements through competitive award processes. The company supplies a comprehensive range of medications across multiple therapeutic domains to military treatment facilities and other government healthcare systems. Kisqali, a specialty oncology medication, aligns with AmerisourceBergen's portfolio of brand-name and specialized pharmaceutical products delivered under its DLA Troop Support Medical contract, enabling the company to efficiently respond to federal medical supply needs through the established indefinite delivery vehicle.
Quick answers
Who was awarded contract SPE2DR26FCZ3M?
SPE2DR26FCZ3M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FCZ3M worth?
The government has obligated $29,459 on SPE2DR26FCZ3M.
Is contract SPE2DR26FCZ3M an order under another contract?
Yes. SPE2DR26FCZ3M is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ3M competed?
The extent of competition for SPE2DR26FCZ3M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award